BioNxt Solutions receives Eurasian Patent for sublingual cladribine platform
BioNxt Solutions Inc. (BioNxt), a bioscience innovator specializing in advanced drug delivery systems, announced that the Eurasian Patent Organization (EAPO) has officially granted Patent No. 051510 (issued November 14, 2025). The patent covers the …